SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739614-22-000052
Filing Date
2022-05-09
Accepted
2022-05-09 16:04:50
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inhibrx-20220331.htm   iXBRL 10-Q 949006
2 EX-31.1 exhibit311q12022.htm EX-31.1 10291
3 EX-31.2 exhibit312q12022.htm EX-31.2 10301
4 EX-32.1 exhibit321q12022.htm EX-32.1 5180
5 EX-32.2 exhibit322q12022.htm EX-32.2 5177
11 inhibrx-20220331_g1.jpg GRAPHIC 304130
  Complete submission text file 0001739614-22-000052.txt   5804822

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inhibrx-20220331.xsd EX-101.SCH 40051
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inhibrx-20220331_cal.xml EX-101.CAL 53341
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inhibrx-20220331_def.xml EX-101.DEF 191038
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inhibrx-20220331_lab.xml EX-101.LAB 480916
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inhibrx-20220331_pre.xml EX-101.PRE 330869
53 EXTRACTED XBRL INSTANCE DOCUMENT inhibrx-20220331_htm.xml XML 700687
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39452 | Film No.: 22904835
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences